Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank73
3Y CAGR+123.9%
5Y CAGR-10.8%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+123.9%/yr
vs -46.0%/yr prior
5Y CAGR
-10.8%/yr
Recent acceleration
Acceleration
+169.9pp
Accelerating
Percentile
P73
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $84.96M | +726.1% |
| 2024 | $10.29M | +14.6% |
| 2023 | $8.98M | +18.5% |
| 2022 | $7.57M | +9.9% |
| 2021 | $6.89M | -95.4% |
| 2020 | $150.41M | +38.7% |
| 2019 | $108.41M | +21.7% |
| 2018 | $89.11M | +31.7% |
| 2017 | $67.65M | +112.5% |
| 2016 | $31.84M | - |